title: Effect of repeated administration of dexfenfluramine on feeding and brain Fos in mice.
abstract: The present study examines whether repeated administration of dexfenfluramine (DFEN) to mice is associated with progressive attenuation of its anorectic action and induction of Fos-immunoreactivity (Fos-ir) in some brain regions, both known effects in rats. ICR:Cd-1 mice were adapted to receiving for 30 min daily a sweetened milk gelatin dessert in addition to ad libitum access to chow. Mice were then injected with either DFEN (5-10 mg/kg) or saline vehicle every other day. These doses of DFEN acutely suppressed intake by approximately 50% and this action was sustained for at least eight injections. The anorectic effect of DFEN was no different between drug-naïve and DFEN-pretreated mice under conditions that produce complete tolerance in rats. In addition, unlike in rats, the acute anorectic effect of m-chlorophenylpiperazine (mCPP) was unaffected by prior DFEN treatment. Mice were perfused after the intake test on the final experimental day and their brain processed for Fos-ir. DFEN induced Fos-ir in brain regions analogous to those reported in rats and, also, as in rats, DFEN pretreatments reduced substantially the Fos-ir induced by acute DFEN in regions including central nucleus of amygdala, bed nucleus of stria terminalis, and the paraventricular hypothalamus (magno- and parvocellular divisions; PVN). Thus, while DFEN pretreatments reduce the effects of DFEN in many brain regions in both rats and mice, mice are unlike rats insofar as there is no tolerance to the anorectic action, at least in the nondeprivation protocol used here.
authors.affiliation: Department of Psychology, University of Florida, PO Box 112250, Gainesville, FL 32611-2250, USA. nrowland@ufl.edu
authors.forename: Neil E
authors.initials: NE
authors.lastname: Rowland
authors.forename: Kimberly
authors.initials: K
authors.lastname: Robertson
authors.forename: D Joy
authors.initials: DJ
authors.lastname: Green
mesh_terms: D000818:Animals; D000855:Anorexia / Q000139:chemically induced; D001921:Brain / Q000187:drug effects* / Q000378:metabolism*; D020372:Dexfenfluramine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004435:Eating / Q000187:drug effects*; D051379:Mice / Q000502:physiology*; D008813:Mice, Inbred ICR; D010879:Piperazines / Q000494:pharmacology; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism*; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage*; D014018:Tissue Distribution
chemical_list: D010879:Piperazines; D016760:Proto-Oncogene Proteins c-fos; D017366:Serotonin Receptor Agonists; D020372:Dexfenfluramine; C015068:1-(3-chlorophenyl)piperazine